14 results · 37ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SHEEP ANTI-HUMAN IGE IMMUNOFIXATION GRADE KIT

FDA 510(k)
FDA Class 2 ·Immunology

Ophthalmic Knife

FDA UDI
KATENA PRODUCTS, INC.·00841668113578·PRESET 600 MICRON KNIFE (BX/5)

PedFuse®

FDA UDI
SPINEFRONTIER, INC.·00190361009276·PedFuse, Rod, Straight, Bulleted, 5.5mm X 60mm

CRADLE SLING ECONOMY

FDA UDI
DARCO INTERNATIONAL, INC.·00609271020788·Extra-large

ODONTOSURGE 3

FDA 510(k)
FDA Class 2 ·Dental

SYNTHES (USA) RESORBABLE TACK SYSTEM

FDA 510(k)
FDA Class 2 ·Dental

LUMA ARCH

FDA Adverse Event
Injury ·LUMALITE, INC.·Product code EEG·July 6, 2004

PORTEX GENERAL ANESTHESIA CIRCUITS

FDA Adverse Event
Malfunction ·SMITHS MEDICAL INTERNATIONAL, LTD.·Product code CAI·May 18, 2022

SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE·Product code FKX·March 13, 2013

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO OPERATIONS MED-REL·Product code MDS·February 16, 2011

RESTORE RECHARGABLE NEUROSTIMULATOR

FDA Adverse Event
Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code LGW·February 8, 2008

bk5000 Ultrasound System w/battery; Model No. 2300-61; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024